Literature DB >> 4197768

Control of surface wound infection: skin versus synthetic grafts.

D G Saymen, P Nathan, I A Holder, E O Hill, B G Macmillan.   

Abstract

Auto-, iso-, or xenografts of skin and synthetics placed on surface wounds freshly contaminated with Pseudomonas aeruginosa stabilizes the wound bacterial population in rats over a 24-h period. When these wounds contained a bacterial contamination established for 24 h prior to grafting, only skin and the synthetic polyhydroxyethylmethacrylate were effective in lowering the initial bacterial concentration. Polyurethane foam and nylon velour were not effective in the established infection model. Skin placed on a contaminated wound for 2 h or longer appeared to equilibrate with the underlying muscle so that the bacterial count per milligram of skin was similar to that of the muscle. It was suggested that this preparation would be useful to obtain an estimate of surface contamination without biopsy of the infected muscle. Skin grafts in place for 2 h significantly lowered the bacterial count in a wound with an established infection. A second decrease occurred between 4 and 24 h after grafting. Histological studies of contaminated and exposed panniculus muscle showed that leukocytes tend to migrate from the muscle surface to its base. Skin grafts and polyhydroxyethylmethacrylate appear to reverse the white cell migration so that the cells move toward the surface of the muscle with preservation of normal staining characteristics in the muscle. It is suggested that this alteration in cell movement after graft application might modify the white cell function and result in a greater bactericidal activity. Apparently, grafts lower bacterial levels in an established infection by modifying the host response to the surface contamination.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4197768      PMCID: PMC380941          DOI: 10.1128/am.25.6.921-934.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  22 in total

1.  PIG SKIN AND BOVINE COLLAGEN AS POSSIBLE TEMPORARY DRESSINGS FOR SKIN WOUNDS.

Authors:  I C SONG; B E BROMBERG; E KOEHNLEIN; M P MOHN
Journal:  Surg Forum       Date:  1963

2.  Resistance to infection in burned patients.

Authors:  H H BALCH
Journal:  Ann Surg       Date:  1963-01       Impact factor: 12.969

3.  Bacterial contamination and infection in the severely burned patient.

Authors:  T G BLOCKER; S R LEWIS; H S JACOBSON; D A GRANT
Journal:  Tex State J Med       Date:  1959-05

4.  The relationship between granulation tissue, bacteria, and skin grafts in burned patients.

Authors:  G G EADE
Journal:  Plast Reconstr Surg Transplant Bull       Date:  1958-07

5.  Postmortem homografts as biological dressings for extensive burns and denuded areas; immediate and preserved homografts as life-saving procedures.

Authors:  J B BROWN; M P FRYER; P RANDALL; M LU
Journal:  Ann Surg       Date:  1953-10       Impact factor: 12.969

6.  Homograft skin for wound coverage. A study of versatility.

Authors:  J M Shuck; B A Pruitt; J A Moncrief
Journal:  Arch Surg       Date:  1969-04

7.  The extended use of skin homografts.

Authors:  J A O'Neill; J L Grosfeld; E T Boles
Journal:  Arch Surg       Date:  1969-08

8.  Evaluation of synthetic films as wound covers.

Authors:  A I Walder; P D May; C P Bingham; J R Wright
Journal:  Trans Am Soc Artif Intern Organs       Date:  1969

9.  Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues.

Authors:  D G Saymen; P Nathan; I A Holder; E O Hill; B G Macmillan
Journal:  Appl Microbiol       Date:  1972-03

10.  An evaluation of methyl 2-cyanoacrylate as a burn dressing.

Authors:  E A Person; C Jelenko; G H Yeager
Journal:  Am Surg       Date:  1967-04       Impact factor: 0.688

View more
  9 in total

1.  Chitosan composite films. Biomedical applications.

Authors:  Galo Cárdenas; Paola Anaya; Carlos von Plessing; Carlos Rojas; Jackeline Sepúlveda
Journal:  J Mater Sci Mater Med       Date:  2007-12-29       Impact factor: 3.896

Review 2.  Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes.

Authors:  Timo W Hakkarainen; Nicole M Kopari; Tam N Pham; Heather L Evans
Journal:  Curr Probl Surg       Date:  2014-06-12       Impact factor: 1.909

3.  Inflammatory inert poly(ethylene glycol)--protein wound dressing improves healing responses in partial- and full-thickness wounds.

Authors:  Kirill I Shingel; Liliana Di Stabile; Jean-Paul Marty; Marie-Pierre Faure
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

4.  Effect of a synthetic dressing formed on a burn wound in rats: a comparison of allografts, collagen sheets, and polyhydroxyethylmethacrylate in the control of wound infection.

Authors:  P Nathan; B G Macmillan; I A Holder
Journal:  Appl Microbiol       Date:  1974-09

5.  The effect of a collagen dressing on contaminated surgical wounds in rats.

Authors:  A Burget; P Nathan; I A Holder; B G Macmillan
Journal:  Langenbecks Arch Chir       Date:  1976-12-22

6.  Human amniotic membrane: a versatile wound dressing.

Authors:  J S Gruss; D W Jirsch
Journal:  Can Med Assoc J       Date:  1978-05-20       Impact factor: 8.262

7.  Fusobacterium necrophorum infection in mice as a model for the study of liver abscess formation and induction of immunity.

Authors:  P M Abe; E S Lennard; J W Holland
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

8.  Sodium hypochlorite decontamination of split-thickness cadaveric skin infected with bacteria and yeast with subsequent isolation and growth of basal cells to confluency in tissue culture.

Authors:  R C Fader; A Maurer; M D Stein; S Abston; D N Herndon
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

9.  Assessment of functional limitation after necrotizing soft tissue infection.

Authors:  Tam N Pham; Merilyn L Moore; Beth A Costa; Joseph Cuschieri; Matthew B Klein
Journal:  J Burn Care Res       Date:  2009 Mar-Apr       Impact factor: 1.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.